May 17, 2020

KPMG and Oracle partner to create exceptional healthcare cloud solutions

Digital health
Cloud
Oracle
healthcare
Catherine Sturman
2 min
healthcare cloud solutions
Global networking company KPMG has recently revealed its new unique solution for the healthcare industry. Enabling clients to move their finance, human...

Global networking company KPMG has recently revealed its new unique solution for the healthcare industry. Enabling clients to move their finance, human resources and supply chain functions to the Oracle Cloud, "Powered Healthcare" is a healthcare version of KPMG's Powered Enterprise solution. 

In a new partnership, Oracle is set to leverage the experience and best practices of KPMG's healthcare industry experts to enhance its cloud solutions for the healthcare industry. KPMG's Powered Healthcare is based on a target operating model for business combined with KPMG's industry-leading practices. 

The result is accelerated client deployments and maximised time –to-value in the Oracle Cloud.  Powered Enterprise offerings for Oracle cover Enterprise Resource Planning (ERP), Human Capital Management (HCM), Enterprise Performance Management (EPM), Supply Chain Management (SCM), Procurement, and Costing and Controls.  

See also

In addition, KPMG and Oracle Consulting Services are jointly developing a delivery model for healthcare implementations that will help reduce client cost and risk.

"KPMG is one of our leading cloud partners, and it has a unique offering in the marketplace with KPMG Powered Enterprise," explained Rod Johnson, SVP North American ERP, EPM & SCM enterprise business.

"KPMG's transformational capabilities will continue to play a key role in helping organisations innovate, adapt and grow in the Oracle Cloud."

"Bringing a tailored Powered Enterprise solution to the healthcare industry can help companies generate business value for key stakeholders, not only by expanding the functionality of the Oracle Healthcare Cloud solution, but also by leveraging the insights from hundreds of healthcare clients," added Linsey Ryan, KPMG Global Oracle Network leader.

Share article

Jun 23, 2021

Introducing Dosis - the AI powered dosing platform

AI
medication
personalisedmedicine
chronicdisease
3 min
Dosis is an AI-powered personalised medication dosing platform that's on a mission to transform chronic disease management

Cloud-based platform Dosis uses AI to help patients and clinicians tailor their medication plans. Shivrat Chhabra, CEO and co-founder, tells us how it works. 

When and why was Dosis founded?
Divya, my co-founder and I founded Dosis in 2017 with the purpose of creating a personalised dosing platform. We see personalisation in so many aspects of our lives, but not in the amount of medication we receive. We came across some research at the University of Louisville that personalised the dosing of a class of drugs called ESAs that are used to treat chronic anaemia. We thought, if commercialised, this could greatly benefit the healthcare industry by introducing precision medicine to drug dosing. 

The research also showed that by taking this personalised approach, less drugs were needed to achieve the same or better outcomes. That meant that patients were exposed to less medication, so there was a lower likelihood of side effects. It also meant that the cost of care was reduced. 

What is the Strategic Anemia Advisor? 
Dosis’s flagship product, Strategic Anemia Advisor (SAA), personalises the dosing of Erythropoiesis Stimulating Agents (ESAs). ESAs are a class of drugs used to treat chronic anaemia, a common complication of chronic kidney disease. 

SAA takes into account a patient’s previous ESA doses and lab levels, determines the patient’s unique response to the drug and outputs an ESA dose recommendation to keep the patient within a specified therapeutic target range. Healthcare providers use SAA as a clinical decision support tool. 

What else is Dosis working on? 
In the near term, we are working on releasing a personalised dosing module for IV iron, another drug that’s used in tandem with ESAs to treat chronic anaemia. We’re also working on personalising the dosing for the three drugs used to treat Mineral Bone Disorder. We’re very excited to expand our platform to these new drugs. 

What are Dosis' strategic goals for the next 2-3 years? 
We strongly believe that personalised dosing will be the standard of care within the next decade, and we’re honored to be a part of making that future a reality. In the next few years, we see Dosis entering partnerships with other companies that operate within value-based care environments, where tools like ours that help reduce cost while maintaining or improving outcomes are extremely useful.

What do you think AI's greatest benefits to healthcare are?
If designed well, AI in healthcare allows for a practical and usable way to deploy solutions that would not be feasible otherwise. For example, it’s possible for someone to manually solve the mathematical equations necessary to personalise drug dosing, but it is just not practical. AI in healthcare offers an exciting path forward for implementing solutions that for so long have appeared impractical or impossible.

Share article